Nothing Special   »   [go: up one dir, main page]

Latest News for: lupine

Edit

Stocks to buy in 2025: Lupin, Ashok Leyland among top 5 stocks that could give ...

The Economic Times 14 Feb 2025
Top brokerage firms have identified key stocks for potential ...
Edit

Lupin Global CFO: Trump tariffs could deny medicines to many in the U.S.

CNBC 13 Feb 2025
... Lupin, warns that Trump tariffs could deny many in the U.S.
Edit

Lupin shares drop 3% after Q3 results

The Economic Times 12 Feb 2025
Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit ...
Edit

Earnings Impact! Lupin share price rebounds around 6% from today's low after strong Q3 results 2025

Live Mint 12 Feb 2025
Lupin's shares recovered after strong Q3 FY25 results, with a net profit of ₹858.9 crore, up 38.8%. North America sales grew 12.3%, contributing 38% to total sales. The stock rose 2.4% to ₹2,116, nearing its January peak of ₹2,403.45 ....
Edit

Lupin posts 39% profit jump on strong US sales growth

Business Line 12 Feb 2025
Pharmaceutical major Lupin Limited reported a 39.5 per cent increase in net profit to ₹855.2 crore for the quarter ended December 31, 2024, driven by robust performance in its North American and European markets.
Edit

Lupin to transfer OTC consumer healthcare business to wholly owned subsidiary for ₹550-650 crore

Business Line 12 Feb 2025
Drugmaker Lupin is transferring its over the counter (OTC) consumer healthcare business to a wholly owned subsidiary for ₹550-650 crore, the company said, after it announced its financial performance for the third quarter (Q3),.
Edit

February 11, 2025 Lupin Q3 FY2025 Results (Lupin Limited)

Public Technologies 12 Feb 2025
Pharma major Lupin Limited [BSE ... Lupin received approval for 6 ANDA from the U.S ... About Lupin ... Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
Edit

February 12, 2025 Lupin Q3 FY2025 Results (Lupin Limited)

Public Technologies 12 Feb 2025
Pharma major Lupin Limited [BSE ... Lupin received approval for 6 ANDA from the U.S ... About Lupin ... Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
Edit

Stocks to Watch: Nykaa, Grasim Industries, Eicher Motors, Lupin, NALCO, and more

Live Mint 11 Feb 2025
Here’s a quick look at stocks likely to be in focus in today's trade ....
Edit

Lulu (previously Lupin)

Muscatine Journal 11 Feb 2025
Little Lulu is just 4 months old, but she is a WORLD CLASS SNUGGLER! This playful pup would love aView on PetFinder ... .
Edit

February 10, 2025 Lupin Receives Approval from U.S. FDA for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% (Lupin Limited)

Public Technologies 10 Feb 2025
Global pharma major Lupin Limited (Lupin) ... Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
Edit

February 10, 2025 Lupin and Natco Receive Approval from U.S. FDA for Bosentan Tablets for Oral Suspension (Lupin Limited)

Public Technologies 10 Feb 2025
Global pharma major Lupin Limited (Lupin) ... Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
Edit

Natco’s generic for PAH gets USFDA nod, marketing partner Lupin to launch product

The Hindu 10 Feb 2025
Natco said it believes it has the sole first-to-file status for the product and consequently eligible for a 180-day exclusivity at the time of launch ....
Edit

Myotonic dystrophy Market Expected to rise, 2034 | Lupin, AMO Pharma Limited, Harmony Biosciences, LLC, ...

GetNews 10 Feb 2025
Several key pharmaceutical companies, including Lupin, AMO Pharma Limited, Harmony Biosciences, LLC, and others, are developing novel products to improve the Myotonic dystrophy treatment outlook.
×